Advisornet Financial’s Biogen BIIB Stock Holding History

Advisornet Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$24K	–	2006
2021 Q4	$24K	Hold	100	–	–	﹤0.01%	1241
2021 Q3	$28K	Hold	100	–	–	﹤0.01%	1156
2021 Q2	$35K	Hold	100	–	–	﹤0.01%	1082
2021 Q1	$28K	Hold	100	–	–	﹤0.01%	1095
2020 Q4	$24K	Hold	100	–	–	﹤0.01%	1078
2020 Q3	$28K	Hold	100	–	–	﹤0.01%	997
2020 Q2	$27K	Buy	+100	New	+$30.1K	﹤0.01%	1020
2020 Q1	–	Sell	-1,000	Closed	-$297K	–	1780
2019 Q4	$297K	Hold	1,000	–	–	0.03%	428
2019 Q3	$233K	Hold	1,000	–	–	0.02%	471
2019 Q2	$234K	Buy	+1,000	New	+$231K	0.03%	422

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Advisornet Financial's BIIB Position: Q2 2026 in Review

Advisornet Financial reduced its Biogen (BIIB) stake by 57% in Q2 2026, selling an estimated $1.53K and leaving 6 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Advisornet Financial first reported a position in BIIB in Q4 2017 and has held it in 35 quarters since. The position peaked at $288K in Q1 2021. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Advisornet Financial held 6 shares of Biogen worth $1.3K as of Q2 2026.
Advisornet Financial sold 8 Biogen shares in Q2 2026, an estimated $1.53K.
Biogen made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1988 holding.
Advisornet Financial first reported a position in Biogen in Q4 2017 and has held it in 35 quarters since.
Advisornet Financial's Biogen position peaked at $288K in Q1 2021.
569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.